Safety and Tolerance Study of IBI355 in Health Volunteers
Clinical trial NCT06110338 · COMPLETED
Trial details
- NCT number
- NCT06110338
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-30
- Primary completion
- 2024-09-20
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.